Evelo Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	17.26	47.94	68.44	68.86	77.83	93.1
Short-Term Investments	-	-	-	-	-	54.82
Cash & Short-Term Investments	17.26	47.94	68.44	68.86	77.83	147.92
Cash Growth	-75.00%	-29.95%	-0.60%	-11.53%	-47.38%	286.76%
Prepaid Expenses	1.67	3.63	2.59	1.86	3.18	3.7
Restricted Cash	-	-	-	0.26	-	-
Total Current Assets	18.94	51.57	71.03	70.98	81.01	151.62
Property, Plant & Equipment	0.89	11.71	15.53	18.24	8.34	6.93
Other Long-Term Assets	0.8	1.16	1.31	1.42	1.57	1.32
Total Assets	20.63	64.44	87.87	90.64	90.92	159.87
Accounts Payable	0.53	1.76	1.6	1.44	0.62	1.52
Accrued Expenses	4.55	7.95	13.07	16.25	8.76	4.97
Current Portion of Leases	-	2.26	1.95	1.67	-	-
Other Current Liabilities	0.74	0.43	0.74	0.46	0.37	2.75
Total Current Liabilities	39.76	12.4	17.36	19.83	9.74	9.24
Long-Term Debt	-	43.61	46.56	30.05	19.63	12.31
Long-Term Leases	-	5.27	7.79	9.99	-	-
Long-Term Unearned Revenue	7.5	7.5	7.5	-	-	-
Other Long-Term Liabilities	0.07	0.66	-	0.28	1.35	1.38
Total Liabilities	47.33	69.43	79.2	60.15	30.72	22.92
Common Stock	0.02	0.11	0.05	0.05	0.03	0.03
Additional Paid-In Capital	561.3	524.12	423.31	322.96	259.02	250.32
Retained Earnings	-588.03	-529.22	-414.7	-292.52	-198.85	-113.38
Comprehensive Income & Other	-	-	-	-	-	-0.02
Total Common Equity	-26.71	-4.99	8.67	30.49	60.2	136.95
Shareholders' Equity	-26.71	-4.99	8.67	30.49	60.2	136.95
Total Liabilities & Equity	20.63	64.44	87.87	90.64	90.92	159.87
Total Debt	33.95	51.14	56.29	41.71	19.63	12.31
Net Cash (Debt)	-16.69	-3.2	12.15	27.15	58.2	135.61
Net Cash Growth	-	-	-55.25%	-53.36%	-57.08%	379.54%
Net Cash Per Share	-1.95	-0.73	4.59	13.75	36.34	124.01
Filing Date Shares Outstanding	18.93	5.55	2.68	2.67	1.61	1.59
Total Common Shares Outstanding	18.85	5.54	2.68	2.37	1.61	1.59
Working Capital	-20.83	39.18	53.66	51.15	71.27	142.39
Book Value Per Share	-1.42	-0.90	3.24	12.84	37.42	86.06
Tangible Book Value	-26.71	-4.99	8.67	30.49	60.2	136.95
Tangible Book Value Per Share	-1.42	-0.90	3.24	12.84	37.42	86.06
Machinery	2.88	10.9	10.78	9.89	8.44	6.04
Construction In Progress	0.09	1.12	1.32	1.08	1.59	1.01
Leasehold Improvements	-	2.16	2.16	2.16	2.01	1.82

Updated Nov 9, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.